Companies: 10,795·Total market cap: $144.5T
Mustang Bio, Inc.

Mustang Bio, Inc.

MBIONASDAQHealthcare● Active
$0.70
+$0.03(+4.49%)
Market Cap$5305011
P/E Ratio—
52W High$7
52W Low$0.531
Overview

Mustang Bio, Inc. (MBIO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001680048 · MBIO · NASDAQ · as of Jun 10, 2026

Filing snapshot

401
Total Filings
10-Q
Latest Form
2026-05-05
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001680048 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-19
Fiscal Year End
Mar 19, 2026
Accession No.
0001104659-26-032063
Primary Document
tmb-20251231x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001680048 · Accession 0001104659-26-032063

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-05
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-04-17Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
10-QQuarterly Report
10-Q
2026-05-05
View
8-KCurrent Report
FORM 8-K
2026-04-17
View
10-KAnnual Report
10-K
2026-03-19
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-01-05
View
8-KCurrent Report
8-K
2025-12-23
View
DEF 14AProxy Statement
DEF 14A
2025-12-03
View
10-QQuarterly Report
10-Q
2025-11-07
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-10-01
View
424B5424B5
424B5
2025-09-05
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-08-12
View
10-QQuarterly Report
10-Q
2025-08-08
View
8-KCurrent Report
FORM 8-K
2025-07-09
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-05-15
View
10-QQuarterly Report
10-Q
2025-05-14
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-05-09
View
Showing 1–15 of 334 filingsForm 4 / 144 hidden· 401 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001680048  |  Exchange: NASDAQ · Healthcare

Mustang Bio, Inc. (NASDAQ: MBIO) has submitted 401 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001680048, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Mustang Bio, Inc.'s most comprehensive regulatory disclosure. The most recent Mustang Bio, Inc. 10-K was filed on 2026-03-19 for fiscal year ending 2026. Historical MBIO 10-K annual reports are available from 2016 through 2026.

Investors researching Mustang Bio, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
MRKR SEC Filings →TRAW SEC Filings →BOLT SEC Filings →IMRN SEC Filings →EVGN SEC Filings →RNAZ SEC Filings →DWTX SEC Filings →ACXP SEC Filings →
→ MBIO Financials→ MBIO Earnings→ MBIO Insider Trades

Frequently Asked Questions

MBIO SEC Filings · 8 questions

Mustang Bio, Inc. (MBIO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 401 filings and access original documents at no cost. Mustang Bio, Inc.'s CIK is 0001680048.

MBIO SEC filingsMustang Bio, Inc. SEC documentsfind MBIO 10-K